US Patent Issued to Lysosomal and Rare Disorders Research and Treatment Center, Rare Cures on July 22 for "Methods and compositions for treating lysosomal storage disorders: ambroxol as treatment agent for Mucopolysaccharidoses III (Sanfilippo syndrome)" (Virginia Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,673, issued on July 22, was assigned to Lysosomal and Rare Disorders Research and Treatment Center Inc. (Fairfax, Va.) and Rare Cures Corp. (Saratoga Springs, N.Y.).

"Methods and compositions for treating lysosomal storage disorders: ambroxol as treatment agent for Mucopolysaccharidoses III (Sanfilippo syndrome)" was invented by Ozlem Goker-Alpan (Fairfax, Va.) and Margarita M. Ivanova (Fairfax, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating MPS III diseases are disclosed. The methods involve administering a therapeutically effective amount of a composition comprising ambroxol to a subject with the disease. Also disclosed ar...